SCHEMBL21292798

SCHEMBL21292798

O=C(NN=Cc1ccc(F)cc1)c1ccc(O)cc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
RAB9A P51151 3/20 0.61
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
POLB P06746 3/20 0.58
RRM1 P23921 1/20 0.57
GCGR P47871 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
NTRK1 P04629 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53
CA9 Q16790 1/20 0.53
MAPT P10636 3/20 0.53
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20115634 1.00 NPC1 (0.61) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL20115428 0.91 MEN1 (0.63) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL21292852 0.91 MEN1 (0.63) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL21292804 0.86 KMT2A (0.58) SMN1; SMN2MEN1KMT2APOLBRRM1
SCHEMBL21292816 0.86 KMT2A (0.58) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL21292818 0.86 KMT2A (0.58) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL21292806 0.86 KMT2A (0.58) SMN1; SMN2MEN1KMT2APOLBRRM1
SCHEMBL20299057 0.86 MEN1 (0.75) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL20115424 0.86 MEN1 (0.75) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL14448892 0.84 NTRK1 (0.72) SMN1; SMN2MEN1KMT2APOLBRRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD NPC1 4801/4885SMN1; SMN2 3566/4885RAB9A 4415/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD NPC1 4801/4885SMN1; SMN2 3566/4885RAB9A 4415/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD NPC1 4801/4885SMN1; SMN2 3566/4885RAB9A 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.